Literature DB >> 31315708

Prevalence of tuberculosis treatment non-adherence in Ethiopia: a systematic review and meta-analysis.

H H Tola1, K Holakouie-Naieni2, E Tesfaye3, M A Mansournia2, M Yaseri2.   

Abstract

<sec> <title>SETTING</title> Non-adherence to treatment is one of the challenges facing global tuberculosis (TB) control. In Ethiopia, an extremely variable and high magnitude of TB treatment non-adherence have been reported from different parts of the country. However, there has been no attempt to estimate the pooled prevalence of non-adherence from this heterogeneous data. </sec> <sec> <title>OBJECTIVE</title> To review the available literature and estimate the overall prevalence of treatment non-adherence among patients with TB on first-line treatment in Ethiopia. </sec> <sec> <title>DESIGN</title> A systematic review and meta-analysis of published articles on TB treatment non-adherence. </sec> <sec> <title>RESULTS</title> We included 26 studies, which contained data on 37 381 patients with TB. The crude prevalence of non-adherence reported by the studies included was extremely variable (range 0.2-35%). The overall pooled estimate of non-adherence prevalence was 10.0% (95%CI 8.0-11.0). The pooled prevalence of patients lost to follow-up alone was 5.0% (95%CI 4.0-6.0), while the pooled prevalence of intermittent non-adherence was 20.0% (95%CI 15.0-25.0). </sec> <sec> <title>CONCLUSION</title> The rate of TB treatment non-adherence in Ethiopia remains too high to achieve target treatment success rates and prevent drug resistance. Implementing an effective patient retention scheme, along with the DOTS strategy, is critical to improving treatment adherence and preventing drug resistance. </sec>.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31315708     DOI: 10.5588/ijtld.18.0672

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  6 in total

1.  Level of and associated factors for non-adherence to anti-tuberculosis treatment among tuberculosis patients in Gamo Gofa zone, southern Ethiopia: cross-sectional study.

Authors:  Dessalegn Ajema; Tamiru Shibru; Temesgen Endalew; Selamawit Gebeyehu
Journal:  BMC Public Health       Date:  2020-11-13       Impact factor: 3.295

2.  Lost to follow-up and associated factors among patients with drug resistant tuberculosis in Ethiopia: A systematic review and meta-analysis.

Authors:  Assefa Andargie; Asressie Molla; Fentaw Tadese; Segenet Zewdie
Journal:  PLoS One       Date:  2021-03-18       Impact factor: 3.240

3.  Protocol of a parallel group Randomized Control Trial (RCT) for Mobile-assisted Medication Adherence Support (Ma-MAS) intervention among Tuberculosis patients.

Authors:  Zekariyas Sahile; Lua Perimal-Lewis; Paul Arbon; Anthony John Maeder
Journal:  PLoS One       Date:  2021-12-31       Impact factor: 3.752

Review 4.  Undernutrition is feeding the tuberculosis pandemic: A perspective.

Authors:  Madeline E Carwile; Natasha S Hochberg; Pranay Sinha
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2022-03-17

5.  Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial.

Authors:  Tsegahun Manyazewal; Yimtubezinash Woldeamanuel; David P Holland; Abebaw Fekadu; Henry M Blumberg; Vincent C Marconi
Journal:  Trials       Date:  2020-05-05       Impact factor: 2.279

6.  Intermittent treatment interruption and its effect on multidrug resistant tuberculosis treatment outcome in Ethiopia.

Authors:  Habteyes H Tola; Kourosh Holakouie-Naieni; Mohammad A Mansournia; Mehdi Yaseri; Ephrem Tesfaye; Zemedu Mahamed; Million Molla Sisay
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.